Jacky Vonderscher
Founder at ENYO Pharma SA
Network origin in Jacky Vonderscher first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
University of Geneva
21
| College/University | Other Consumer Services | 21 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.
15
| Holding Company | Biotechnology | 15 |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles.
4
| Private Company | Drugstore Chains | 4 |
Institut National des Sciences Appliquées de Toulouse
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jacky Vonderscher via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| TRAWS PHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| University of Bath | College/University | Undergraduate Degree Undergraduate Degree | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Investment Committee Member Private Equity Investor | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Beerse Betonhandel
 Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Regional Banks | Corporate Officer/Principal | |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
| École Supérieure de Physique et de Chimie de Paris | College/University | Undergraduate Degree | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Director/Board Member Private Equity Investor | |
SIX Swiss Exchange AG
 SIX Swiss Exchange AG Investment Banks/BrokersFinance SIX Swiss Exchange AG operates as a stock exchange. It distributes a range of indices; and offers market data for shares, bonds, ETFs and funds, ETPs, indices, statistics, and data services. The firm enables to list and trade in segments, including equities, bonds, exchange traded funds (ETFs), exchange traded products (ETPs), derivatives, sponsored funds, sponsored foreign shares, warrants, and structured products. The company was founded in 1850 and is headquartered in Zurich, Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BIOM'UP | Medical Specialties | Director/Board Member Director/Board Member | |
Sigurd Rück AG
 Sigurd Rück AG Insurance Brokers/ServicesFinance Part of Saipem SpA, Sigurd Rück AG is a Swiss company that provides insurance services. The company is based in Zurich, Switzerland. | Insurance Brokers/Services | Chairman | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
Sygnature Discovery Ltd.
 Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chairman | |
| Fidinam Australasia Real Estate Pte Ltd. | Director/Board Member | ||
| Fly Away SA | Miscellaneous | Chairman | |
| Saunion SA | Director/Board Member | ||
| Terzerina SA | Director/Board Member | ||
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Founder Director/Board Member | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Swiss Takeover Board | General Government | Corporate Officer/Principal |
Statistics
International
| United States | 16 |
| France | 16 |
| Switzerland | 12 |
| United Kingdom | 6 |
| Germany | 2 |
Sectoral
| Health Technology | 29 |
| Finance | 9 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 435 |
| Corporate Officer/Principal | 158 |
| Independent Dir/Board Member | 104 |
| Chairman | 77 |
| Chief Executive Officer | 40 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Ed Mathers Mathers | 47 |
| Patrick Aebischer | 35 |
| Iain Dukes | 32 |
| Massimo G. Pedrazzini | 27 |
| Maina Bhaman | 26 |
| Louis Joseph Nisbet | 24 |
| Anne VanLent | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Jason Robert Dinges | 22 |
| Barbara Duncan | 22 |
| Manuel Leuthold | 21 |
| Laurent Arthaud | 21 |
| Henry Peter | 20 |
| Brian O'Callaghan | 20 |
- Stock Market
- Insiders
- Jacky Vonderscher
- Company connections
